US FDA Developing Database Of Medical Review Decisions, Gottlieb Tells Congress
Executive Summary
'Knowledge management platform' will identify agency's scientific precedents; Commissioner Gottlieb says it is one of FDA's top three initiatives, along with continuous manufacturing and real-time safety monitoring.
You may also be interested in...
Pfizer Uses Layered Knowledge Management To Guide Tech Transfers
Pfizer has developed a multilayered knowledge management program that aims to ease the tech transfer process by harnessing institutional knowledge into one place. The program allows employees to ensure that processes remain stable during tech transfer by exploring all available process knowledge available on the product.
US FDA Wants Generic Sponsors To Know If Anything Missing Before Submitting ANDA
Proposed assessment system upgrade would add automation to potentially reduce refuse-to-file actions and review cycles.
Sanofi's Admelog, a Humalog Follow-On, Approved In US As 'Black Hole' For Insulins Looms
Short-acting insulin approved under 505(b)(2) pathway appears poised to receive three years of Hatch-Waxman exclusivity but would lose nine months of this protection under FDA's current interpretation of the 'transition provisions' for certain protein products that take effect in March 2020.